Granza Bio

Granza Bio: Reprogramming Immunity for Target-Specific Medicines. Headquartered in San Francisco, CA, United States. Current operating status: active.

Oomira checked this YC company record against source evidence and keeps the current facts, observed dates, and provenance visible before the interactive app loads.

Summary

Reprogramming Immunity for Target-Specific Medicines

2026-06-12 · 1 source

Description

Granza Bio is developing programmable therapeutics for the immune system. Our platform is built on the foundational discovery of immune “superkiller” attack particles — the natura...

2026-06-12 · 1 source

Website

https://www.granzabio.com/

2026-06-12 · 2 sources

Hiring

no

2026-06-13 · 1 source

Headquarters

San Francisco, CA, United States

2026-06-13 · 1 source

Operating status

active

2026-06-12 · 1 source

Industry

Healthcare

2026-06-13 · 1 source

Open the full YC audit or continue into the interactive frozen world below.